bullish
Wuxi Biologics Placement: A Larger Deal but Performance Track Record Weighs
522 Views31 Oct 2019 18:52
Wuxi Biologics is looking to raise upto US$770m by selling 35 million primary shares and selling 35million shares held by its main shareholder Wuxi...
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 3-minute read)
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- ECM Weekly (19 Jan 2020) - Mr. DIY, UTI AMC, Sinopharm, Sunac, Jinxin, China Lit19 Jan 2020
- ECM Weekly (12 Jan 2020) - Jiumaojiu, I-Mab, Phoenix Tree, Burger King India12 Jan 2020
- Wuxi Biologics Placement: Almost All of the past Deals Have Done Well, Would Bid near the Bottom End09 Jan 2020
- Wuxi Biologics Placement: Past Deal Did Well Despite Sell-Down Overhang18 Jun 2019
- Wuxi Biologics Placement - Past Deals Have Done Well but Progressive Returns Are Getting Lower20 Mar 2019
x